Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q53995826)
Watch
English
Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
editorial
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Lamivudine treatment in patients with decompensated hepatitis B cirrhosis: for whom and when?
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
main subject
liver cirrhosis
0 references
lamivudine
1 reference
based on heuristic
inferred from title
author name string
Fontana RJ
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
Lok AS
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
publication date
1 August 2000
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
published in
Journal of Hepatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
volume
33
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
page(s)
329-332
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
cites work
Hepatitis B: Evolving Epidemiology and Implications for Control
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transection of the oesophagus for bleeding oesophageal varices
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival in chronic hepatitis B. An analysis of 379 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: a case-control study in Italy. Brescia HCC Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine as initial treatment for chronic hepatitis B in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine resistance inimmunocompetent chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutations in hepatitis B DNA polymerase associated with resistance to lamivudine do not confer resistance to adefovir in vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2980376-1
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0168-8278(00)80376-1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
PubMed publication ID
10952253
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10952253
retrieved
23 May 2018
reference URL
http://europepmc.org/abstract/MED/10952253
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit